Pluristem Says Second Patient Given - Life-Saving' Cells Died

Pluristem Therapeutics Inc. said a second of the three patients given the company's experimental stem cells has died after Pluristem touted the treatments as "life-saving." Pluristem shares soared after the Haifa, Israel-based company issued news releases in May, August and September announcing the treatments.

http://washpost.bloomberg.com/Story?docId=1376-MD7WF30D9L3C01-1KL8BKGECO7VKM7M412GU56A6D